DNTH
$72.09-3.27%
Dianthus Therapeutics Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.010%US Stock Market 0.007%Russell 3000 0.006%
Dianthus Therapeutics Inc. monthly returns
Dianthus Therapeutics Inc. has averaged 2.50% per month, positive in 50% of months. Month-by-month returns for Dianthus Therapeutics Inc. (DNTH) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+2.5%
94 months
Best month
+87.0%
Feb 2019
Worst month
-65.2%
Dec 2022
Positive months
50%
of all months
Dianthus Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -18.1% | |
| Sep 2026 | -16.6% | |
| Aug 2026 | -1.2% | |
| Jul 2026 | +9.7% | |
| Jun 2026 | +4.8% | |
| May 2026 | +5.9% | |
| Apr 2026 | +4.6% | |
| Mar 2026 | +52.1% | |
| Feb 2026 | +3.4% | |
| Jan 2026 | +29.6% | |
| Dec 2025 | -6.3% | |
| Nov 2025 | +25.7% | |
| Oct 2025 | -11.1% | |
| Sep 2025 | +66.9% | |
| Aug 2025 | +14.0% | |
| Jul 2025 | +11.0% | |
| Jun 2025 | +7.1% | |
| May 2025 | -20.4% | |
| Apr 2025 | +20.5% | |
| Mar 2025 | -16.0% | |
| Feb 2025 | -2.5% | |
| Jan 2025 | +1.6% | |
| Dec 2024 | -9.1% | |
| Nov 2024 | -13.9% | |
| Oct 2024 | +1.8% | |
| Sep 2024 | -5.0% | |
| Aug 2024 | -3.2% | |
| Jul 2024 | +15.1% | |
| Jun 2024 | +19.8% | |
| May 2024 | +1.2% | |
| Apr 2024 | -28.8% | |
| Mar 2024 | +21.2% | |
| Feb 2024 | +30.3% | |
| Jan 2024 | +82.7% | |
| Dec 2023 | -7.0% | |
| Nov 2023 | -6.8% | |
| Oct 2023 | -12.2% | |
| Sep 2023 | +13.9% | |
| Aug 2023 | -6.3% | |
| Jul 2023 | +5.3% | |
| Jun 2023 | +16.9% | |
| May 2023 | -16.7% | |
| Apr 2023 | -1.3% | |
| Mar 2023 | -2.5% | |
| Feb 2023 | +47.3% | |
| Jan 2023 | +37.5% | |
| Dec 2022 | -65.2% | |
| Nov 2022 | -10.9% | |
| Oct 2022 | -8.5% | |
| Sep 2022 | -19.9% | |
| Aug 2022 | +10.0% | |
| Jul 2022 | +33.3% | |
| Jun 2022 | +3.4% | |
| May 2022 | -18.9% | |
| Apr 2022 | -50.7% | |
| Mar 2022 | -7.9% | |
| Feb 2022 | -3.7% | |
| Jan 2022 | -26.2% | |
| Dec 2021 | -21.3% | |
| Nov 2021 | -12.0% | |
| Oct 2021 | -12.1% | |
| Sep 2021 | +13.8% | |
| Aug 2021 | -10.1% | |
| Jul 2021 | -27.2% | |
| Jun 2021 | -20.8% | |
| May 2021 | +6.0% | |
| Apr 2021 | -1.6% | |
| Mar 2021 | +12.7% | |
| Feb 2021 | +18.9% | |
| Jan 2021 | +12.8% | |
| Dec 2020 | +9.7% | |
| Nov 2020 | +13.3% | |
| Oct 2020 | -7.2% | |
| Sep 2020 | -6.5% | |
| Aug 2020 | +3.6% | |
| Jul 2020 | -6.5% | |
| Jun 2020 | -15.0% | |
| May 2020 | +8.5% | |
| Apr 2020 | +29.8% | |
| Mar 2020 | -46.6% | |
| Feb 2020 | -1.0% | |
| Jan 2020 | -21.6% | |
| Dec 2019 | +14.5% | |
| Nov 2019 | +27.2% | |
| Oct 2019 | +1.5% | |
| Sep 2019 | -0.7% | |
| Aug 2019 | -23.5% | |
| Jul 2019 | -8.4% | |
| Jun 2019 | +0.6% | |
| May 2019 | +1.7% | |
| Apr 2019 | -12.5% | |
| Mar 2019 | +25.6% | |
| Feb 2019 | +87.0% | |
| Jan 2019 | +23.0% | |
| Dec 2018 | -41.7% | |
| Nov 2018 | +11.5% | |
| Oct 2018 | -27.0% | |
| Sep 2018 | -17.7% | |
| Aug 2018 | +6.2% | |
| Jul 2018 | +1.9% |
Monthly total return (since Nov 2021)#
-50%0%50%
Nov 2021-12%
Dec 2021-21%
Jan 2022-26%2022
Feb 2022-3.7%
Mar 2022-7.9%
Apr 2022-51%
May 2022-19%
Jun 2022+3.4%
Jul 2022+33%
Aug 2022+10%
Sep 2022-20%
Oct 2022-8.5%
Nov 2022-11%
Dec 2022-65%
Jan 2023+38%2023
Feb 2023+47%
Mar 2023-2.5%
Apr 2023-1.3%
May 2023-17%
Jun 2023+17%
Jul 2023+5.3%
Aug 2023-6.3%
Sep 2023+14%
Oct 2023-12%
Nov 2023-6.8%
Dec 2023-7.0%
Jan 2024+83%2024
Feb 2024+30%
Mar 2024+21%
Apr 2024-29%
May 2024+1.2%
Jun 2024+20%
Jul 2024+15%
Aug 2024-3.2%
Sep 2024-5.0%
Oct 2024+1.8%
Nov 2024-14%
Dec 2024-9.1%
Jan 2025+1.6%2025
Feb 2025-2.5%
Mar 2025-16%
Apr 2025+20%
May 2025-20%
Jun 2025+7.1%
Jul 2025+11%
Aug 2025+14%
Sep 2025+67%
Oct 2025-11%
Nov 2025+26%
Dec 2025-6.3%
Jan 2026+30%2026
Feb 2026+3.4%
Mar 2026+52%
Apr 2026+4.6%
May 2026+5.9%
Jun 2026+4.8%
Jul 2026+9.7%
Aug 2026-1.2%
Sep 2026-17%
Oct 2026-18%
Dianthus Therapeutics Inc. returns by calendar month#
Every month of every year since 2019, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -18.13% — 8th of 8 Octobers since 2019 at the last close; the average October returned -6.8%.
| Month | −90%0+90% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +17.4% | +17.9% | 75% | +82.7% 2024 | -26.2% 2022 | |
| Feb | +22.5% | +11.1% | 63% | +87.0% 2019 | -3.7% 2022 | |
| Mar | +4.8% | +5.1% | 50% | +52.1% 2026 | -46.6% 2020 | |
| Apr | -5.0% | -1.4% | 38% | +29.8% 2020 | -50.7% 2022 | |
| May | -4.1% | +1.5% | 63% | +8.5% 2020 | -20.4% 2025 | |
| Jun | +2.1% | +4.1% | 75% | +19.8% 2024 | -20.8% 2021 | |
| Jul | +4.0% | +7.5% | 63% | +33.3% 2022 | -27.2% 2021 | |
| Aug | -2.1% | -2.2% | 38% | +14.0% 2025 | -23.5% 2019 | |
| Sep | +5.7% | -2.9% | 38% | +66.9% 2025 | -19.9% 2022 | |
| Oct | -6.8% | -8.5% | 29% | +1.8% 2024 | -12.2% 2023 | |
| Nov | +3.2% | -6.8% | 43% | +27.2% 2019 | -13.9% 2024 | |
| Dec | -12.1% | -7.0% | 29% | +14.5% 2019 | -65.2% 2022 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from DNTH's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Dianthus Therapeutics Inc.'s average monthly return?
- Dianthus Therapeutics Inc. (DNTH) has averaged about 2.50% per month, positive in roughly 50% of months. The best month was Feb 2019 (+87.0%) and the worst was Dec 2022 (-65.2%).
More on Dianthus Therapeutics Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100